The non-steroidal anti-inflammatory drugs (NSAIDs) market has witnessed significant growth over the past few years owing to the growing prevalence of chronic inflammatory conditions like arthritis, back pain, and muscle pain across global populations. NSAIDs are one of the most commonly used medications for the treatment of pain and inflammation associated with these conditions. Some major NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib.

These drugs work by blocking cyclooxygenase (COX) enzymes that produce prostaglandins, which are chemicals in the body that cause pain and inflammation. Non-Steroidal Anti-Inflammatory Drugs Market are available in the form of tablets, capsules, gels, and creams over the counter as well as through prescription from physicians.



The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 24.4 Bn in 2024 and is expected to reach USD 36 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.



Key Takeaways

Key players - Key players operating in the non-steroidal anti-inflammatory drugs market are Pfizer, GlaxoSmithKline, Bayer, Novartis, Sanofi, and Abbott. Pfizer leads the global NSAIDs market with top-selling brands like Celebrex and Advil.



Key opportunities - Rise in geriatric population globally prone to arthritis and other inflammatory conditions will drive the demand for NSAIDs. Also, availability of OTC NSAIDs without prescription provides opportunities for self-medication and increased sales volumes.



Global expansion - Major players are focusing on expanding their product reach in high growth emerging markets like Asia Pacific and Latin America through strategic partnerships and acquisitions.



Market drivers

Rising geriatric population globally is one of the major drivers for the non-steroidal anti-inflammatory drugs market. People aged 60 years and above are more susceptible to chronic pain and inflammatory conditions like osteoarthritis and back pain owing to natural ageing process and wear & tear of cartilage. According to the UN, the number of people aged 60 years or above is expected to more than double by 2050 and reach around 2 billion. The growing pool of geriatric population prone to inflammatory conditions is expected to significantly drive the demand for NSAIDs for pain relief over the forecast period.

PEST Analysis

Political: Regulations regarding the usage, testing, and marketing of NSAIDs are set by regulatory bodies in individual countries and regions.

Economic: Spending on healthcare and availability of healthcare insurance affects the demand for NSAIDs. Prices of raw materials and production costs impact the pharmaceutical companies.

Social: Growing awareness about inflammation-related diseases and Over-the-counter availability and usage of NSAIDs for pain relief. Advancement in understanding of inflammatory diseases and conditions also influence the market.

Technological: Development of advanced drug delivery mechanisms helps improve efficacy and reduces side effects of NSAIDs. Continuous research into new molecules and combinations also expands treatment options.



Geographical Regions with High Market Concentration

The North American and European regions account for the major share of the global NSAIDs market in terms of value. This is due to high healthcare expenditure, advanced healthcare systems, growing geriatric population prone to inflammation-related conditions in these regions. Wide acceptance and availability of NSAIDs as over-the-counter drugs also contributes to high consumption.



Fastest Growing Regional Market

The Asia Pacific region is poised to grow at the fastest pace during the forecast period. This is attributed to factors like rising healthcare spending, growing medical tourism industry, increasing awareness about inflammation-related diseases, and growing geriatric population in emerging economies like China and India. Improving access to healthcare through various government initiatives is also supporting the growth of the NSAIDs market in Asia Pacific region.

About Author:                                                                                                                                                          

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)